| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 572.44 | 92 |
| GSM780708 | Untreated after 4 days (C2_1) | 372.097 | 89 |
| GSM780709 | Untreated after 4 days (C3_1) | 407.652 | 90 |
| GSM780719 | Untreated after 4 days (C1_2) | 513.219 | 92 |
| GSM780720 | Untreated after 4 days (C2_2) | 428.174 | 90 |
| GSM780721 | Untreated after 4 days (C3_2) | 382.705 | 89 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 355.582 | 89 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 484.8 | 91 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 490.199 | 91 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 355.755 | 89 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 516.436 | 92 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 508.428 | 92 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 564.691 | 92 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 413.883 | 90 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 503.258 | 92 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 558.155 | 92 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 478.065 | 91 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 498.166 | 92 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 583.051 | 93 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 470.427 | 91 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 450.752 | 91 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 619.773 | 93 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 509.695 | 92 |